International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Michael Sargent BinkleyJamie E FlerlageKerry Joane SavageSaad AkhtarRaphael E SteinerXiao-Yin ZhangMichael J DickinsonAnca PricaAjay MajorPeter G HendricksonDavid HopkinsAndrea K NgCarla CasuloJonathan BaronKenneth B RobertsJalila AlkendiAlex BaloghUmberto RicardiPallawi TorkaLena SpechtRavindu De SilvaKeir PickardLindsay J BlazinMichael HenryChristine Moore SmithDaniel HalperinJessica BradyBernadette BrennanMaria Anatolevna SenchenkoMarie ReevesBradford S HoppeStephanie A TerezakisDipti TalaulikarMarco PicardiYoulia KirovaPaige FergussonEliza A HawkesDenise LeeNicole Wong DooAllison BarracloughChan Yoon Y CheahMatthew KuNada HamadHoward MutsandoMichael GilbertsonTamara MarconiNicholas ViialaMatthew John MaurerDennis A EichenauerRichard T Hoppenull nullPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
In this comprehensive study of all ages of patients with NLPHL, we develop the LP-IPS to identify high-risk patients and inform upcoming prospective clinical trials evaluating de-escalation of therapy for patients with low LP-IPS scores (<2).